The expression of stanniocalcin-1 (STC1), a glycoprotein involved in calcium/phosphate homeostasis, is enhanced in hypoxic conditions and promotes tumor cell invasion and resistance to cisplatin. This evidence concerns the gene STC1 and neoplasm.